LARINATE 60mg powder for injection medication leaflet

P01BE03 artesunate • Antiparasitic products, insecticides and repellents | Antimalarials | Artemisinin and derivatives, plain

Artesunate is a medication used in the treatment of severe malaria caused by Plasmodium falciparum. It is a semisynthetic derivative of artemisinin that acts rapidly against the parasite by generating reactive oxygen species that destroy infected cells.

Artesunate is administered intravenously or intramuscularly and is recommended in cases of severe malaria, particularly in patients who cannot tolerate oral therapy. It is often used in combination with other antimalarial drugs to prevent recurrence of the infection.

Common side effects include nausea, dizziness, fever, and injection site reactions. In rare cases, severe allergic reactions or delayed hemolysis may occur, requiring careful monitoring.

Artesunate is an essential medication in the treatment of severe malaria, helping to reduce mortality and improve outcomes for patients affected by this serious disease.

General data about LARINATE 60mg

Substance: artesunate

Date of last drug list: 01-06-2016

Commercial code: W61957001

Concentration: 60mg

Pharmaceutical form: powder for injection

Quantity: 1

Product type: generic

Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Pharmaceutical forms available for artesunate

Concentrations available for artesunate

110mg, 60mg